title: In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors.
abstract: Induced pluripotent stem (iPS) cells that result from the reprogramming of somatic cells to a pluripotent state by forced expression of defined factors are offering new opportunities for regenerative medicine. Such clinical applications of iPS cells have been limited so far, mainly due to the poor efficiency of the existing reprogramming methodologies and the risk of the generated iPS cells to form tumors upon implantation. We hypothesized that the reprogramming of somatic cells towards pluripotency could be achieved in vivo by gene transfer of reprogramming factors. In order to efficiently reprogram cells in vivo, high levels of the Yamanaka (OKSM) transcription factors need to be expressed at the target tissue. This can be achieved by using different viral or nonviral gene vectors depending on the target tissue. In this particular study, hydrodynamic tail-vein (HTV) injection of plasmid DNA was used to deliver the OKSM factors to mouse hepatocytes. This provided proof-of-evidence of in vivo reprogramming of adult, somatic cells towards a pluripotent state with high efficiency and fast kinetics. Furthermore no tumor or teratoma formation was observed in situ. It can be concluded that reprogramming somatic cells in vivo may offer a potential approach to induce enhanced pluripotency rapidly, efficiently, and safely compared to in vitro performed protocols and can be applied to different tissue types in the future.
authors.affiliation: Nanomedicine Lab, UCL School of Pharmacy, University College London.
authors.forename: Açelya
authors.initials: A
authors.lastname: Yilmazer
authors.forename: Irene
authors.initials: I
authors.lastname: de Lázaro
authors.forename: Cyrill
authors.initials: C
authors.lastname: Bussy
authors.forename: Kostas
authors.initials: K
authors.lastname: Kostarelos
mesh_terms: D000818:Animals; D065150:Cellular Reprogramming / Q000235:genetics / Q000502:physiology*; D004247:DNA / Q000008:administration & dosage / Q000235:genetics; D005260:Female; D018014:Gene Transfer Techniques; D022781:Hepatocytes / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D057026:Induced Pluripotent Stem Cells / Q000166:cytology / Q000502:physiology*; D007275:Injections, Intravenous; D051379:Mice; D008807:Mice, Inbred BALB C; D010957:Plasmids / Q000008:administration & dosage / Q000235:genetics; D014157:Transcription Factors / Q000096:biosynthesis* / Q000235:genetics; D014162:Transfection
chemical_list: D014157:Transcription Factors; D004247:DNA